SciVision Biotech Inc. (TPE:1786)
Taiwan
· Delayed Price · Currency is TWD 67.80
+1.80 (2.73%)
Mar 10, 2026, 9:38 AM CST
SciVision Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 4,765 | 5,241 | 7,466 | 5,254 | 3,587 | 3,283 | Upgrade
|
| Market Cap Growth | -44.69% | -29.80% | 42.10% | 46.46% | 9.27% | -12.78% | Upgrade
|
| Enterprise Value | 4,195 | 4,767 | 6,908 | 4,936 | 3,075 | 3,197 | Upgrade
|
| Last Close Price | 66.00 | 72.60 | 100.46 | 73.38 | 50.19 | 44.30 | Upgrade
|
| PE Ratio | 30.28 | 32.28 | 30.82 | 29.54 | 25.32 | 32.28 | Upgrade
|
| PS Ratio | 5.37 | 5.91 | 8.45 | 7.37 | 6.44 | 6.49 | Upgrade
|
| PB Ratio | 2.41 | 2.65 | 3.94 | 3.23 | 2.37 | 2.26 | Upgrade
|
| P/TBV Ratio | 2.41 | 2.65 | 3.94 | 3.24 | 2.38 | 2.27 | Upgrade
|
| P/FCF Ratio | 212.11 | 233.32 | 31.76 | 20.42 | 21.48 | 45.14 | Upgrade
|
| P/OCF Ratio | 38.43 | 42.27 | 27.67 | 19.32 | 19.71 | 33.33 | Upgrade
|
| EV/Sales Ratio | 4.73 | 5.38 | 7.82 | 6.92 | 5.52 | 6.32 | Upgrade
|
| EV/EBITDA Ratio | 15.52 | 17.63 | 22.27 | 18.88 | 15.74 | 18.47 | Upgrade
|
| EV/EBIT Ratio | 22.09 | 25.10 | 27.84 | 24.72 | 22.85 | 26.22 | Upgrade
|
| EV/FCF Ratio | 186.77 | 212.22 | 29.38 | 19.18 | 18.41 | 43.95 | Upgrade
|
| Debt / Equity Ratio | 0.25 | 0.25 | 0.12 | 0.21 | 0.27 | 0.44 | Upgrade
|
| Debt / EBITDA Ratio | 1.79 | 1.79 | 0.72 | 1.32 | 2.10 | 3.62 | Upgrade
|
| Debt / FCF Ratio | 21.60 | 21.60 | 0.95 | 1.35 | 2.47 | 8.70 | Upgrade
|
| Net Debt / Equity Ratio | -0.29 | -0.29 | -0.31 | -0.24 | -0.14 | -0.04 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.11 | -2.11 | -1.87 | -1.52 | -1.05 | -0.36 | Upgrade
|
| Net Debt / FCF Ratio | -25.34 | -25.34 | -2.47 | -1.54 | -1.23 | -0.86 | Upgrade
|
| Asset Turnover | 0.35 | 0.35 | 0.39 | 0.34 | 0.26 | 0.24 | Upgrade
|
| Inventory Turnover | 3.22 | 3.22 | 2.86 | 2.19 | 2.08 | 2.54 | Upgrade
|
| Quick Ratio | 7.43 | 7.43 | 2.91 | 5.80 | 5.54 | 1.82 | Upgrade
|
| Current Ratio | 8.17 | 8.17 | 3.46 | 6.92 | 6.88 | 2.17 | Upgrade
|
| Return on Equity (ROE) | 8.37% | 8.37% | 13.75% | 11.34% | 9.57% | 7.13% | Upgrade
|
| Return on Assets (ROA) | 4.72% | 4.72% | 6.87% | 5.86% | 3.86% | 3.67% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.66% | 12.22% | 16.20% | 13.35% | 8.16% | 7.92% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.60% | 7.60% | 12.30% | 9.90% | 6.80% | 6.60% | Upgrade
|
| Earnings Yield | 3.41% | 3.10% | 3.25% | 3.39% | 3.95% | 3.10% | Upgrade
|
| FCF Yield | 0.47% | 0.43% | 3.15% | 4.90% | 4.66% | 2.21% | Upgrade
|
| Dividend Yield | 4.64% | - | 3.23% | 3.41% | 3.98% | 3.21% | Upgrade
|
| Payout Ratio | 144.06% | 144.06% | 69.90% | 74.93% | 66.21% | 57.57% | Upgrade
|
| Buyback Yield / Dilution | 0.00% | 0.00% | 2.58% | -2.39% | -5.18% | -0.61% | Upgrade
|
| Total Shareholder Return | 4.64% | 0.00% | 5.82% | 1.02% | -1.20% | 2.59% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.